FDG Injection Site Extravasation
Autor: | Luke Sonoda, Subhadip Ghosh-Ray, Jeanette Dickson, Wai Lup Wong, Bal Sanghera |
---|---|
Rok vydání: | 2012 |
Předmět: |
Male
medicine.medical_specialty Lung Neoplasms Multimodal Imaging Proximal ulna Injections Fluorodeoxyglucose F18 Carcinoma Non-Small-Cell Lung Injection site medicine Humans Radiology Nuclear Medicine and imaging Neoplasm Metastasis neoplasms Lung business.industry Significant difference General Medicine Middle Aged Extravasation medicine.anatomical_structure Bronchial carcinoma Positron-Emission Tomography Injection site extravasation Radiology Skeletal metastasis Tomography X-Ray Computed Nuclear medicine business Extravasation of Diagnostic and Therapeutic Materials |
Zdroj: | Clinical Nuclear Medicine. 37:1115-1116 |
ISSN: | 0363-9762 |
DOI: | 10.1097/rlu.0b013e318266cbdb |
Popis: | 18F-FDG PET/CT plays an important role in the management of non-small-cell lung cancers (NSCLC). The treatment options for NSCLC depend upon the initial staging of the disease. The authors report a case with a potential pitfall of overlooking a site of FDG uptake as radiopharmaceutical extravasation at an injection site. The PET/CT demonstrated a T2a N2 bronchial carcinoma, with a solitary focus of FDG uptake at the left antecubital fossa where FDG was administered. Careful interpretation of the images reveals a solitary skeletal metastasis in the left proximal ulna, which makes the disease stage IV rather than IIIA, leading to a significant difference in treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |